SAN DIEGO–(BUSINESS WIRE)–Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will present at the 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, which will be held at the Westin Grand Central Hotel in New York City on Thursday, November 17, 2016.
About Pathway Genomics
Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, CA our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with actionable and accurate precision healthcare information to improve health and wellness. The company’s program with IBM Watson is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users with personalized health and wellness information based on the individual’s health history.
Pathway believes in the power of “genetics first” to help make proactive, informed decisions about health and lifestyle. Our physician-ordered tests include assays for diet and weight loss, circulating tumor DNA (liquid biopsy), hereditary cancer, pharmacogenomics and carrier screening. For more about Pathway Genomics, visit www.pathway.com and follow us on Facebook, LinkedIn and Twitter.
Kamal Adawi, Chief Financial Officer